Aromha, Inc.

Other Health CareHealthTechDiagnosticsAlzheimer's

📍 Potomac, MD, United States

StreetZero Signal 53

Be the first to signal interest

About Aromha, Inc.

Aromha, Inc. develops the AROMHA brain health test, a remote olfactory assessment to screen for cognitive impairment associated with Alzheimer’s disease. The company’s test targets early detection given that pathology can accumulate 15–20 years before memory symptoms. Co-founders S.R. and M.W.A. own shares in Aromha, Inc., while C.M. and A.D.A. serve as consultants.

LATEST FUNDINGPrivate Placement

$75K

Announced 2026-09-24

TOTAL RAISED$75,000

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Aromha, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQPotomac, MD, United States

Industry

Other Health Care

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Aromha, Inc. completed a $75,000 private placement with undisclosed investors.
The company’s AROMHA test is a remote olfactory assessment for cognitive impairment.
Research on the test appeared in Scientific Reports with company co-founders as authors.
Location listed as Potomac, MD in the Washington DC-Baltimore area.

Ask StreetZero about Aromha, Inc.

Put our AI to work on this deal.

What is Aromha, Inc.'s value proposition?Who are Aromha, Inc.'s competitors?Why does this raise matter?Summarize Aromha, Inc. for an investor.

Similar companies

Other Other Health Care deals, ranked by Signal.

Precision Neuroscience Corp

$250.0M

Alpfa Medical, Inc.

$80.3M

PFARADIGM Health, Inc.

$31.1M

Falcon Hospice, L.P.

$20.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.